US pharma major Eli Lilly (NYSE: LLY) has secured full approval from the US FDA for its oral drug Inluriyo (imlunestrant) in ...

Pharmacies in Denmark would be able to hand out an alternative pack of a medicine during a supply squeeze without first ...

German family-owned drugmaker Grünenthal today announced an agreement with Bayer to acquire Stivarga (regorafenib), an oral ...

French genetic medicines company Cyllene Therapeutics has appointed Dr Marc Grasso as executive vice president and chief financial officer (CFO).

UK-based clinical-stage ophthalmic gene therapy biotech Beacon Therapeutics today announced positive top-line results for its registration-enabling VISTA trial evaluating laruparetigene zovaparvovec ...

US drugmaker AbbVie has entered a multi-year collaboration with Iambic, the US clinical-stage life sciences and technology company, to apply the latter firm's AI-driven discovery platform to small ...

US pharma giant Merck & Co said Japan's Ministry of Health, Labor and Welfare has approved Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) for subcutaneous use across all indications ...

Australian biotech company Telix Pharmaceuticals today announced it has signed a strategic agreement to lead a merger with ...

China has set a target for domestically developed first-in-class drugs to account for at least 25% of the global total by ...

Canadian neuroscience specialist Xenon Pharmaceuticals saw its shares fall more than 30% on Friday after it disclosed a voluntary pause in enrollment of new patients across its ongoing clinical ...

The US Food and Drug Administration (FDA) has accepted Insmed’s supplemental New Drug Application (sNDA) for review of Arikayce (amikacin liposome inhalation suspension) for the treatment of ...

Danish drugmaker Novo has added three early-stage obesity programs to its pipeline through an asset purchase agreement with Kallyope, a privately held New York biotech company. The deal was disclosed ...